With the recognition of elevated succinate causing aberrant activation of CDK5, the anti-CDK5 inhibitor MRT3-007 was shown to suppress tumor growth in vitro as well as in xenograft mouse models with SDHB knockout (Gupta et al. 2022). This evidence concerns the gene SDHB and neoplasm.